Lemborexant Impurity 11 NEW

Lemborexant Impurity 11;1450904-94-5

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

• Product Number: L072011
  English Name: Lemborexant Impurity 11
  English Alias: ((1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropyl)methyl acetate
  CAS Number: 1450904-94-5
  Molecular Formula: C19H21FN2O3
  Molecular Weight: 344.38

• 
  

• Product Advantages: Lemborexant Impurity 11 has a high degree of purity and good stability. It can maintain its chemical properties stable under different experimental conditions, providing a reliable reference substance for pharmaceutical impurity analysis. It can effectively improve the accuracy and repeatability of impurity detection results, ensuring the reliability of data in pharmaceutical quality research.
  Application Fields: It is mainly applied in the quality control and research and development process of Lemborexant drugs. As an impurity reference standard, it is used to establish and validate the detection methods of Lemborexant impurities, ensuring the sensitivity and specificity of detection methods. In the drug production process, it can be used to monitor the generation and changes of impurities, helping to optimize the production process and ensure that the impurity content of drugs meets the specified standards. In the study of drug stability, it analyzes the change trend of this impurity during storage, providing an important basis for determining the shelf life and storage conditions of drugs.
  Background Description: Lemborexant is a drug used to treat insomnia. The quality of drugs is crucial to the treatment effect and medication safety of patients. Impurities in drugs may affect the safety and effectiveness of drugs. Therefore, impurity research is a key part of drug research and development and quality control. As a related impurity of Lemborexant, the research on the properties, content and change rules of Lemborexant Impurity 11 helps to comprehensively evaluate the quality of Lemborexant drugs and ensure the safety and effectiveness of clinical medication.
  Research Status: Currently, research on Lemborexant Impurity 11 is continuously deepening. In terms of detection technology, more advanced and sensitive analytical methods, such as Ultra - Performance Liquid Chromatography - Tandem Mass Spectrometry (UPLC - MS/MS), are constantly being explored to achieve precise detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors of this impurity are deeply analyzed by simulating the drug synthesis process and storage environment, providing theoretical support for controlling impurities from the source. At the same time, research on the impact of this impurity on the safety and effectiveness of Lemborexant drugs has also been gradually carried out, aiming to further improve the understanding of the quality of Lemborexant drugs.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!